Data / Form D filings / Endo, Inc.
Endo, Inc.: Form D filings
Endo, Inc., a pharmaceuticals company in Malvern, PA, filed 2 Form D notices with the SEC in 2024. The latest, on May 6, 2024, reports $170.6 million sold of a $170.6 million offering to 404 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1400 Atwater Drive, Malvern, PA, 19355
- Phone
- (484) 216-0000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2008861
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2024 | Amendment | $170,574,224 | $170,574,224 | 404 | Mar 21, 2024 | sec.gov | |
| Mar 21, 2024 | New notice | Indefinite | $0 | 55 | Mar 21, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott Hirsch | Director | |
| Paul Efron | Director | |
| Paul Herendeen | Director | |
| Marc Yoskowitz | Director | |
| Patrick Barry | Executive Officer | |
| Blaise Coleman | Executive Officer, Director | |
| Matthew Maletta | Executive Officer | |
| Sophia Langlois | Director | |
| Frank Raciti | Executive Officer | |
| Mark Bradley | Executive Officer, Director | |
| Andy Pasternak | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of May 6, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Endo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.